X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
99
PharmaCompass offers a list of Tetrahydrozoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tetrahydrozoline manufacturer or Tetrahydrozoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tetrahydrozoline manufacturer or Tetrahydrozoline supplier.
PharmaCompass also assists you with knowing the Tetrahydrozoline API Price utilized in the formulation of products. Tetrahydrozoline API Price is not always fixed or binding as the Tetrahydrozoline Price is obtained through a variety of data sources. The Tetrahydrozoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tetrahydrozoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrahydrozoline, including repackagers and relabelers. The FDA regulates Tetrahydrozoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrahydrozoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tetrahydrozoline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tetrahydrozoline supplier is an individual or a company that provides Tetrahydrozoline active pharmaceutical ingredient (API) or Tetrahydrozoline finished formulations upon request. The Tetrahydrozoline suppliers may include Tetrahydrozoline API manufacturers, exporters, distributors and traders.
click here to find a list of Tetrahydrozoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tetrahydrozoline DMF (Drug Master File) is a document detailing the whole manufacturing process of Tetrahydrozoline active pharmaceutical ingredient (API) in detail. Different forms of Tetrahydrozoline DMFs exist exist since differing nations have different regulations, such as Tetrahydrozoline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tetrahydrozoline DMF submitted to regulatory agencies in the US is known as a USDMF. Tetrahydrozoline USDMF includes data on Tetrahydrozoline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tetrahydrozoline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tetrahydrozoline suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tetrahydrozoline Drug Master File in Japan (Tetrahydrozoline JDMF) empowers Tetrahydrozoline API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tetrahydrozoline JDMF during the approval evaluation for pharmaceutical products. At the time of Tetrahydrozoline JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tetrahydrozoline suppliers with JDMF on PharmaCompass.
A Tetrahydrozoline CEP of the European Pharmacopoeia monograph is often referred to as a Tetrahydrozoline Certificate of Suitability (COS). The purpose of a Tetrahydrozoline CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tetrahydrozoline EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tetrahydrozoline to their clients by showing that a Tetrahydrozoline CEP has been issued for it. The manufacturer submits a Tetrahydrozoline CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tetrahydrozoline CEP holder for the record. Additionally, the data presented in the Tetrahydrozoline CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tetrahydrozoline DMF.
A Tetrahydrozoline CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tetrahydrozoline CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tetrahydrozoline suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tetrahydrozoline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tetrahydrozoline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tetrahydrozoline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tetrahydrozoline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tetrahydrozoline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tetrahydrozoline suppliers with NDC on PharmaCompass.
Tetrahydrozoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tetrahydrozoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tetrahydrozoline GMP manufacturer or Tetrahydrozoline GMP API supplier for your needs.
A Tetrahydrozoline CoA (Certificate of Analysis) is a formal document that attests to Tetrahydrozoline's compliance with Tetrahydrozoline specifications and serves as a tool for batch-level quality control.
Tetrahydrozoline CoA mostly includes findings from lab analyses of a specific batch. For each Tetrahydrozoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tetrahydrozoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Tetrahydrozoline EP), Tetrahydrozoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tetrahydrozoline USP).
Market Place
